DOTRECOGIN ALFA (ACTIVATED) TREATMENT PROLONGS FILTER SURVIVAL TIME IN PATIENTS WITH SEVERE SEPSIS ON CONTINUOUS VENOVENOUS HEMOFILTRATION | Publicación